• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by OraSure Technologies Inc.

    10/4/24 1:30:36 PM ET
    $OSUR
    Medical/Dental Instruments
    Health Care
    Get the next $OSUR alert in real time by email
    SC 13G 1 formsc13g-10042024_051033.htm FORM schedule-13g


     
     


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934


     
    ORASURE TECHNOLOGIES INC
    (Name of Issuer)
    Common Stock
    (Title of Class of Securities)
    68554V108
    (CUSIP Number)
    September 30, 2024
    (Date of Event Which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [ x ] Rule 13d-1(b)

    [   ] Rule 13d-1(c)

    [   ] Rule 13d-1(d)



    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     
     


     
    CUSIP No. 68554V108
      (1)   

    Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)

     

        Neuberger Berman Group LLC

        61-1591182

      (2)  
    Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  
    (b)   Membership in Group is Disclaimed
      (3)  

    SEC Use Only

     

      (4)  

    Citizenship or Place of Organization

     

        Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       (5)    

    Sole Voting Power

     

        0

       (6)   

    Shared Voting Power

     

        2972808

       (7)   

    Sole Dispositive Power

     

        0

       (8)   

    Shared Dispositive Power

     

        3927692

    (9)

     

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

        3927692

    (10)

     

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares     [ x ]

     

        (See Instructions)

    (11)

     

    Percent of Class Represented by Amount in Row (9)

     

        5.27%

    (12)

     

    Type of Reporting Person (See Instructions)

     

        HC


    CUSIP No. 68554V108
      (1)   

    Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)

     

        Neuberger Berman Investment Advisers LLC

        02-0654486

      (2)  
    Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  
    (b)   Membership in Group is Disclaimed
      (3)  

    SEC Use Only

     

      (4)  

    Citizenship or Place of Organization

     

        Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       (5)    

    Sole Voting Power

     

        0

       (6)   

    Shared Voting Power

     

        2841582

       (7)   

    Sole Dispositive Power

     

        0

       (8)   

    Shared Dispositive Power

     

        3627258

    (9)

     

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

        3627258

    (10)

     

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares   [   ]

     

        (See Instructions)

    (11)

     

    Percent of Class Represented by Amount in Row (9)

     

        4.86%

    (12)

     

    Type of Reporting Person (See Instructions)

     

        IA


    Item 1.
    (a) Name of Issuer
    (b) Address of Issuer's Principal Executive Offices
    200 E First ST
    Bethlehem, Pennsylvania, 18015

    Item 2.
    (a) Name of Person Filing
    Neuberger Berman Group LLC
    Neuberger Berman Investment Advisers LLC
    (b) Address of Principal Business Office or, if none, Residence
    1290 Avenue of the Americas New York, NY 10104
    (c) Citizenship
    Delaware
    (d) Title of Class of Securities
    Common Stock
    (e) CUSIP Number
    68554V108

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)
    [   ]
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)
    [   ]
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)
    [   ]
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)
    [   ]
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)
    [   ]
    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
    (f)
    [   ]
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
    (g)
    [   ]
    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)
    [   ]
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)
    [   ]
    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)
    [ x ]
    Group, in accordance with §240.13d-1(b)(1)(ii)(J).

    Item 4.
    (a) Amount beneficially owned:
    3,927,692

    Neuberger Berman Trust Co N.A., Neuberger Berman Trust Co of Delaware N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC, and Neuberger Berman
    Investment Advisers LLC and certain affiliated persons may be deemed to beneficially own the securities covered by this report in their various fiduciary capacities by virtue of the
    provisions of Exchange Act Rule 13d-3. Neuberger Berman Group LLC, through its subsidiaries Neuberger Berman Investment Advisers Holdings LLC and Neuberger Trust
    Holdings LLC controls Neuberger Berman Trust Co N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC, Neuberger Berman Trust Co of Delaware N.A. and
    Neuberger Berman Investment Advisers LLC and certain affiliated persons.
    This report is not an admission that any of these entities are the beneficial owner of the securities covered by this report and each of Neuberger Berman Group LLC, Neuberger
    Berman Investment Advisers Holdings LLC, Neuberger Trust Holdings LLC, Neuberger Berman Trust Co N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC,
    Neuberger Berman Trust Co of Delaware N.A. and Neuberger Berman Investment Advisers LLC and certain affiliated persons disclaim beneficial ownership of the securities
    covered by this statement pursuant to Exchange Act Rule 13d-4.
    The information in this filing reports securities of the issuer that may be deemed to be beneficially owned by Neuberger Berman Group LLC, Neuberger Berman Investment
    Advisers Holdings LLC, Neuberger Trust Holdings LLC, Neuberger Berman Trust Co N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC, Neuberger Berman Trust
    Co of Delaware N.A. and Neuberger Berman Investment Advisers LLC ("NBG Filers"). The securities of the issuer, if any, that may be deemed to be beneficially owned by NB
    Alternatives Advisers LLC and other subsidiaries of Neuberger Berman Group LLC that are separated from the NBG Filers by an information barrier in accordance with SEC
    Release No. 34-39538 (January 12, 1998) are not reflected in this filing.
    (b) Percent of class:
    5.27%
    (c) Number of shares as to which the person has:
    (i) Sole power to vote or to direct the vote
    0
    (ii) Shared power to vote or to direct the vote
    2,972,808
    (iii) Sole power to dispose or to direct the disposition of
    0
    (iv) Shared power to dispose or to direct the disposition of
    3,927,692

    Item 5. Ownership of Five Percent or Less of a Class
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [   ]

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    Neuberger Berman Group LLC and its affiliates may be deemed to be beneficial owners of securities for purposes of Exchange Act Rule 13d-3 because they or certain affiliated persons
    have shared power to retain, dispose of or vote the securities of unrelated clients. Neuberger Berman Group LLC or its affiliated persons do not, however, have any economic interest in
    the securities of those clients. The clients have the sole right to receive and the power to direct the receipt of dividends from or proceeds from the sale of such securities. Other than named
    in this filing, no one client has an interest of more than 5% of the issuer.
    With regard to the shares set forth under item 4(c)(ii), Neuberger Berman Group LLC may be deemed to be the beneficial owner for purposes of Rule 13d-3 because certain affiliated
    persons have shared power to retain, dispose of and vote the securities. In addition to the holdings of individual advisory clients, Neuberger Berman Investment Advisers LLC serves as
    investment manager of Neuberger Berman Group LLC's various registered mutual funds which hold such shares. The holdings belonging to clients of Neuberger Berman Trust Co N.A.,
    Neuberger Berman Trust Co of Delaware N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC and Neuberger Berman Investment Advisers LLC are also aggregated to
    comprise the holdings referenced herein.
    In addition to the shares set forth under Item 4(c)(ii) for which Neuberger entities also have shared power to dispose of the shares, item 4(c)(iv) also includes shares from individual client
    accounts over which Neuberger Berman Investment Advisers LLC has shared power to dispose but does not have voting power over these shares. The holdings of Neuberger Berman
    Trust Co N.A., Neuberger Berman Trust Co of Delaware N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC and Neuberger Berman Investment Advisers LLC, are also
    aggregated to comprise the holdings referenced herein.

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
    N/A

    Item 8. Identification and Classification of Members of the Group.
    N/A

    Item 9. Notice of Dissolution of Group.
    N/A

    Item 10. Certification.
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
     


     
    SIGNATURES
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
    Date:   October 4, 2024
    Neuberger Berman Group LLC
    By: /s/ Brad Cetron

    Name: Brad Cetron
    Title: Managing Director
    Date:   October 4, 2024
    Neuberger Berman Investment Advisers LLC
    By: /s/ Brad Cetron

    Name: Brad Cetron
    Title: Managing Director


    Get the next $OSUR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $OSUR

    DatePrice TargetRatingAnalyst
    1/3/2023$5.00In-line
    Evercore ISI
    2/24/2022$15.00 → $12.00Buy
    Citigroup
    9/22/2021Outperform → Market Perform
    Raymond James
    8/4/2021$11.00 → $12.50Outperform
    Raymond James
    6/28/2021$12.00 → $11.00Outperform
    Raymond James
    More analyst ratings

    $OSUR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CEO Eglinton Manner Carrie covered exercise/tax liability with 193,249 shares and was granted 335,710 shares, increasing direct ownership by 8% to 1,830,827 units (SEC Form 4)

      4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

      6/5/25 7:16:13 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • Director Kenny John P. was granted 71,017 shares, increasing direct ownership by 102% to 140,547 units (SEC Form 4)

      4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

      5/15/25 4:46:39 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • Director Gagliano Nancy J covered exercise/tax liability with 4,387 shares and was granted 71,017 shares, increasing direct ownership by 73% to 158,154 units (SEC Form 4)

      4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

      5/15/25 4:46:26 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care

    $OSUR
    SEC Filings

    See more
    • SEC Form EFFECT filed by OraSure Technologies Inc.

      EFFECT - ORASURE TECHNOLOGIES INC (0001116463) (Filer)

      5/30/25 12:15:20 AM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • SEC Form S-8 filed by OraSure Technologies Inc.

      S-8 - ORASURE TECHNOLOGIES INC (0001116463) (Filer)

      5/20/25 5:26:03 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • SEC Form S-3 filed by OraSure Technologies Inc.

      S-3 - ORASURE TECHNOLOGIES INC (0001116463) (Filer)

      5/20/25 5:13:17 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care

    $OSUR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing

      IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food and Drug Administration (FDA) cleared direct-to-consumer (DTC) test for celiac disease genetics, today announced a commercial collaboration with OraSure Technologies, Inc. (NASDAQ:OSUR) manufacturer of ORAcollect®·Dx, the only FDA cleared saliva collection device for general over-the-counter (OTC) use. The collaboration expands consumer access to at-home celiac genetic testing.  Celiac disease, the most common intestinal autoimmune disease worldwide, is triggered by dietary gluten in people who carry the DQ2 and/or DQ8 celiac risk genes. Individuals who test negative

      5/14/25 8:00:00 AM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • OraSure Announces First Quarter 2025 Financial Results

      BETHLEHEM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended March 31, 2025. "Our Q1 results were consistent with our expectations. Our customers continue to demonstrate their preference for our differentiated products in delivering on their important health objectives, even while uncertainty remains elevated related to government funding sources for some segments," said OraSure President and CEO Carrie Eglinton Manner. "We are making good progress in advancing our innovation roadmap, including multiple new prod

      5/7/25 4:05:00 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

      BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET on May 7, 2025. A webcast of the conference call will be available on the investor relations page of OraSure's website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure's website shortly after the call has ended and will be available for approximately one year. For participants interested

      4/23/25 4:05:00 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care

    $OSUR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Evercore ISI resumed coverage on OraSure with a new price target

      Evercore ISI resumed coverage of OraSure with a rating of In-line and set a new price target of $5.00

      1/3/23 8:07:55 AM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • Citigroup reiterated coverage on OraSure Technologies with a new price target

      Citigroup reiterated coverage of OraSure Technologies with a rating of Buy and set a new price target of $12.00 from $15.00 previously

      2/24/22 8:34:18 AM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • OraSure Technologies downgraded by Raymond James

      Raymond James downgraded OraSure Technologies from Outperform to Market Perform

      9/22/21 5:02:16 AM ET
      $OSUR
      Medical/Dental Instruments
      Health Care

    $OSUR
    Leadership Updates

    Live Leadership Updates

    See more
    • KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

      NEW YORK, June 7, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 24, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from the S

      6/7/24 6:09:00 PM ET
      $ADTN
      $ALTR
      $ATNI
      $BMRN
      Telecommunications Equipment
      Utilities
      Computer Software: Prepackaged Software
      Technology
    • NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

      Former Head of OraSure Technologies Joins at Key Stage Leading up to Company's Product Launch NOWDiagnostics (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-class technology and platforms, today announced the appointment of Dr. Stephen S. Tang, Ph.D., MBA, as the chairman of the company's board of directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321747977/en/NOWDiagnostics (NOWDx) Welcomes Dr. Stephen S. Tang as Chairman of the Board (Photo: Business Wire) Dr. Tang is a longtime veteran of the medical diagnostic industry. He led OraSure Technologies, Inc. (NASDA

      3/21/24 8:31:00 AM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • OraSure Technologies Announces the Retirement of Jack E. Jerrett and Appointment of Agnieszka M. Gallagher as General Counsel, Chief Compliance Officer and Secretary

      BETHLEHEM, Pa., Nov. 09, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that after almost 21 years of service to the Company, Jack E. Jerrett is retiring as the Company's Senior Vice President, General Counsel, Chief Compliance Officer and Secretary, effective as of December 31, 2021. Agnieszka M. Gallagher, who most recently served as the Chief Ethics and Compliance Officer at Alnylam Pharmaceuticals has been hired by the Company to fill Jack's roles as the new General Counsel, Chief Compliance Officer and Secretary. "Jack has been a stalwart and extremely

      11/9/21 7:05:00 AM ET
      $OSUR
      Medical/Dental Instruments
      Health Care

    $OSUR
    Financials

    Live finance-specific insights

    See more

    $OSUR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $OSUR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • OraSure Announces First Quarter 2025 Financial Results

      BETHLEHEM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended March 31, 2025. "Our Q1 results were consistent with our expectations. Our customers continue to demonstrate their preference for our differentiated products in delivering on their important health objectives, even while uncertainty remains elevated related to government funding sources for some segments," said OraSure President and CEO Carrie Eglinton Manner. "We are making good progress in advancing our innovation roadmap, including multiple new prod

      5/7/25 4:05:00 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

      BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET on May 7, 2025. A webcast of the conference call will be available on the investor relations page of OraSure's website at https://orasure.gcs-web.com/events-and-presentations. Please click on the webcast link and follow the prompts for registration and access at least 10 minutes prior to the call. The webcast will be archived on OraSure's website shortly after the call has ended and will be available for approximately one year. For participants interested

      4/23/25 4:05:00 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • OraSure Reports Fourth Quarter 2024 Financial Results

      BETHLEHEM, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended December 31, 2024. "Our Q4 revenue was consistent with our expectations, including 10% growth in our core revenue. We continue to see signs of gradual recovery in our key end markets, and we are diversifying our business by expanding our product portfolio and adding new customers, offset by elevated uncertainty for some of our existing customers related to government funding sources," said OraSure President and CEO Carrie Eglinton Manner. "We made tre

      2/25/25 4:05:00 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • Director Gagliano Nancy J bought $39,270 worth of shares (12,750 units at $3.08), increasing direct ownership by 16% to 91,524 units (SEC Form 4)

      4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

      3/3/25 9:08:13 AM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • President & CEO Eglinton Manner Carrie bought $100,027 worth of shares (28,670 units at $3.49), increasing direct ownership by 2% to 1,288,334 units (SEC Form 4)

      4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

      3/3/25 9:07:25 AM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • President & CEO Eglinton Manner Carrie bought $247,378 worth of shares (78,625 units at $3.15), increasing direct ownership by 7% to 1,259,664 units (SEC Form 4)

      4 - ORASURE TECHNOLOGIES INC (0001116463) (Issuer)

      2/27/25 9:14:53 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by OraSure Technologies Inc.

      SC 13G/A - ORASURE TECHNOLOGIES INC (0001116463) (Subject)

      11/12/24 4:46:06 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by OraSure Technologies Inc.

      SC 13G/A - ORASURE TECHNOLOGIES INC (0001116463) (Subject)

      11/4/24 1:18:55 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by OraSure Technologies Inc.

      SC 13G - ORASURE TECHNOLOGIES INC (0001116463) (Subject)

      10/4/24 1:30:36 PM ET
      $OSUR
      Medical/Dental Instruments
      Health Care